← Every company
Fox Corp Patents
What Fox Corp has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
FOXA on carbonthat →Filings on file
28
Granted
1
Still pending
27
Filed under
19 names
28 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| Antibodies To Cell Adhesion Molecule-Related/Down-Regulated By Oncogenes (CDON) And Uses ThereofA61P 35/00, C07K 16/2803, G01N 33/57545, C07K2317/34, C07K2317/73, C07K2317/76Filed as Institute For Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center2026-03-20Denise C. Connolly | pending |
| TREATMENT OF TUMORS WITH MIRNA TARGETING CDK4/CDK6C12N 15/1135, A61P 35/00, A61K 45/06, C12N 15/113, C12N2310/14, C12N2310/141, C12N2320/30Filed as Institute For Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center2026-03-11Amriti R. Lulla | pending |
| Mitogen-Activated Protein Kinase Kinase 1/2 (MEK1/2) Degraders Combined with BCL-2 Inhibitors for the Treatment of CancerA61K 31/427, A61P 35/00, A61K 31/21, A61K 31/404, A61K 31/635, A61K 31/7105, A61K 39/0011, C12N 15/113, C12N2310/11Filed as Institute For Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center2026-03-11James S. Duncan | pending |
| WOOD PLANK AND METHOD OF MANUFACTURING THE SAMEB29C 48/907, B29C 48/175, B29C 48/297, B29C 48/92, B29C 48/022, B29C 48/17, B29C 48/09, B29C 48/07, B29C 48/30, B29C 48/362, B29C 48/49, B29C2948/926, B29C 48/29, B29C 48/12, B29K2995/0021, B44F 9/02Filed as Green Fox Plastics, LLC2026-03-10Daniel Mark SCHLABACH | pending |
| METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCERFiled as INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER2026-03-04CIHANGIR DUY | pending |
| COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCERFiled as INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER2026-03-04WILLIAM RAINOW | pending |
| SUPPLY SYSTEM FOR AGRICULTURAL EQUIPMENTFiled as SMITH FOX LLC2026-03-04WILLIAM C. SMITH | pending |
| APPORTION STRUCTURE FOR APPLICATION OF GELATINOUS OR VISCOUS SOLUTIONA61M 3/0279, A61M 31/00, A61M2210/0618, A61M2210/0662Filed as Fox Valley Innovations, LLC2026-02-27Robert J. Millay | pending |
| Recomposition of reactive oxygen species confers resilience to treatment-induced oxidative stressFiled as Institute For Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center2026-02-26Dr. Cihangir DUY | pending |
| METHODS FOR PROTEIN LABELING BASED ON INDUCIBLE TETRAZINE LIGATIONFiled as JOSEPH M. FOX2026-02-17COLIN THORPE | pending |
| MOVABLE CAMERA WITH LIDAR FOR SPORTS BROADCASTING AND GAMEPLAYG01S 17/86, G06V 20/20, G06V 40/10, G06V 20/42, G06V 20/44, H04N 23/695, H04N 23/90, H04N 23/611, A63B 71/0605, A63B 71/0622, A63B2071/0636, A63B2071/0647, A63B2220/05, A63B2220/13, A63B2220/806, A63B2220/89, A63B2243/0025, G01S 7/4813, G01S 17/08, G01S 17/66, G01S 17/89, G03B 17/561Filed as Fox Sports Productions, LLC2026-02-09Zachary Fields | pending |
| METHODS OF TREATING CANCERA61P 35/00, C07C 311/21, A61K 31/18, A61K 31/4439, C07C 311/39, C07C 311/43, C07D 401/12Filed as Institute For Cancer Research D/B/A The Research Institute of Fox Chase Cancer Center2026-02-04Alfonso Bellacosa | pending |
| Treatment Of Nicotinamide Phosphoribosyltransferase (NAMPT) Related DiseasesA61K 38/10, A61P 35/00, A61K 31/403, A61K 31/44, A61K 31/4545, A61K 31/506, A61K 31/537, A61K 31/5386Filed as INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER2026-02-03Dr. Johnvesly Basappa | pending |
| COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCERS BY TRIGGERING ANTI-VIRAL RESPONSEC12N 15/1137, A61P 35/00, A61K 31/403, A61K 31/7105, A61K 45/06, C07K 16/2803, C07K 16/2818, C07K 16/2827, C12N2310/11, C12N2310/14, C12N2310/531, C12Y 306/04013Filed as INSTITUTE FOR CANCER RESEARCH d/b/a THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER2025-12-18Israel CAÑADAS | pending |
| TARGETED DEGRADERS OF HIV-1 NEF FOR THE TREATMENT OF HIV DISEASEA61K 47/55, A61K 47/545, A61P 31/18Filed as Fox Chase Chemical Diversity Center, Inc.2025-12-10Thomas E. Smithgall | pending |
| USE OF A GROUND POWDERED POMACE AS A STANDARDIZING AGENT FOR HYDROCOLLOIDSFiled as Herbstreith & Fox GmbH & Co. KG Pektin-Fabriken2025-11-25Gerhard F. FOX | pending |
| COMPOUNDS THAT RE-ACTIVATE MUTANT P53A61K 31/549Filed as INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCE CENTER2025-11-24John Karanicolas | pending |
| COMPOUNDS THAT RE-ACTIVATE MUTANT P53A61K 31/4196, C07D 249/08Filed as INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER2025-11-24John KARANICOLAS | pending |
| COMPOUNDS THAT RE-ACTIVATE MUTANT P53Filed as INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER2025-11-24JOHN KARANICOLAS | pending |
| SHELF-STABLE DECHLORINATING SOLUTIONS FOR WATER AND RELATED METHODS FOR USE AND MAKING THEREOFC02F 1/70, A23K 10/00, C02F 1/66, C02F 1/68, C02F2101/12, C02F2209/29, C02F2303/02, C02F2303/185Filed as Swamp Fox Innovations, LLC2025-10-03Larry Todd Banner | pending |
| System and method for plant productionA01G 31/008, A01G 31/00, A01G 31/02, Y02P 60/21, A01C 1/00, A01G 9/24, G06Q 10/063, G06Q 50/02Filed as Peter Fox2025-09-19Peter Fox | pending |
| APPORTION STRUCTURE FOR APPLICATION OF GELATINOUS OR VISCOUS SOLUTIONA61M 3/0279, A61M 31/00, A61M2210/0618, A61M2210/0662Filed as Fox Valley Innovations, LLC2025-08-18Robert J. Millay | pending |
| APPORTION STRUCTURE FOR APPLICATION OF GELATINOUS OR VISCOUS SOLUTIONFiled as FOX VALLEY INNOVATIONS, LLC2025-08-18ROBERT J. MILLAY | pending |
| COMPOSITIONS AND METHODS FOR INHIBITING DNMT1 METHYLATION ACTIVITY FOR REDUCING CHEMOTHERAPY INDUCED AMPLIFICTION AND REARRANGEMRNT IN MIXED LINEAGE LEUKEMIA (MLL)Filed as INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER2025-07-28JOHNATHAN R. WHETSTINE | pending |
| GENETICALLY MODIFIED NK-92 CELL LINEA61K 35/17, C07K 16/2887, C12N 5/0646, A61P 43/00, A61P 35/02, A61P 35/04, A61P 35/00, A61K2239/48, A61K2239/31, A61K2239/38, A61K 40/35, A61K 40/30, A61K 40/42, A61K 40/15, A61K 39/3955, A61K 39/39558, A61K2039/5156, A61K2039/572, A61K2300/00, C07K 14/55, C07K 14/70535, C07K 16/2803, C07K 16/2827, C07K 16/32, C07K2317/24, C07K2317/732, C12N 9/1205, C12N 15/85, C12N2501/2302, C12N2501/48, C12N2501/599, C12N2501/727, C12N2510/00, C12N2830/20Filed as Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center2025-07-17Tien Lee | pending |
| METHOD, APPARATUS, AND COMPUTER-READABLE MEDIUM FOR GENERATING A VIEW OF AN AUGMENTED REALITY ENVIRONMENTFiled as FOX SPORTS PRODUCTIONS, LLC2025-06-14ZAC FIELDS | pending |
| METHOD, APPARATUS, AND COMPUTER-READABLE MEDIUM FOR GENERATING A VIEW OF AN AUGMENTED REALITY ENVIRONMENTG06T 19/006Filed as Fox Sports Productions, LLC2025-06-13Zac Fields | pending |
| Tubing Anchor with Locking Lug RingE21B 23/01Filed as Silver Fox Completion Services, Inc.2025-06-13Kelly Kykkanen | 12553301 |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on FOXA
Company overviewEverything on FOXA in one place, with the price.SEC filingsWhat FOXA's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat FOXA's own officers and directors buy and sell.Executive payWhat FOXA awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in FOXA.Funds holding itWhich funds and ETFs hold FOXA, and how big a bet.LobbyingWhat FOXA spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on FOXA's account, and who they worked for.Federal contractsWhat federal agencies pay FOXA.